General MedicationsPOWDER,FOR SOLUTIONStandard

PIPERACILLIN AND TAZOBACTAM

PIPERACILLIN,TAZOBACTAM

Standard Dose

0.5G/1VIAL

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview PIPERACILLIN AND TAZOBACTAM is listed in Drugs@FDA under application 217409 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN,TAZOBACTAM Form and strength INJECTION;POWDER,FOR SOLUTION - 0.5G/1VIAL Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview PIPERACILLIN AND TAZOBACTAM is listed in Drugs@FDA under application 217409 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PIPERACILLIN,TAZOBACTAM Form and strength INJECTION;POWDER,FOR SOLUTION - 0.5G/1VIAL Sponsor EUGIA PHARMA Submission history Latest submission status date: 2024-12-03 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.